PharmaBlue aims to contribute to a world where patients with unmet medical needs have better access to a variety of safe, effective healthcare products, and innovative treatments.
PharmaBlue is a Partner for Innovative Pharmaceutical Companies
We are your Medium/Long term partner to get and run your Early Access Program in France.
We provide Exploitant services to our clients for rapidly marketing their approved medicines in France (orphan or unmet medical need).
2015: PharmaBlue is founded in Sophia-Antipolis (south of France) to complement BlueReg Group offerered services. PharmaBlue is a “Laboratoire Exploitant” (authorized by the ANSM) enabling innovative pharmaceutical companies to market early access medicines under ATU.
2017: PharmaBlue pharmaceutical site is moved to Paris to facilitate international exchanges.
2020: PharmaBlue’s Exploitant Establishment licensed is inspected by ANSM French National Agency for the Safety of Medicines and Health Products and successfully meet all the requirements.
2021: PharmaBlue is acquired by PharmaLex. In France, there is a major regulation change for Early Access, well handled by PharmaBlue that has obtained its first Authorization under the new regulation.
2022: PharmaBlue pursue its growth with the creation of two dedicated departments : Scientific Affairs and Quality.
2023: PharmaLex group from which PharmaBlue belongs to is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives..
2024: Valerie Colin PharmD, is appointed Head of PharmaBlue.
Our consultants are highly qualified with practical experience in the pharmaceutical industry. To date, PharmaBlue supports its clients based in Europe and in the United States through more than 58 projects to obtain Early Access Programs.
PharmaBlue is an established operating pharmaceutical company in France with “Exploitant” status.
PharmaBlue holds a robust quality management system and is authorized by the French Medicines Agency (ANSM).
Our team is composed of registered pharmacists or specialists, with significant experience in providing expert support to clients.
PharmaBlue provides “Exploitant” services to Pharmaceutical companies looking for a partner to launch their drugs on the French market.
We have a significant experience in supporting clients to obtain early access programs in France (EAP previously called ATU).
We carry the responsibilities related to the distribution of pharmaceutical products in France (products with early access or marketing authorization – MA).
Senior Director Head Of PharmaBlue
Director Quality Chief Pharmaceutical Officer
Director Project Manager